Neogen Chemicals Beheer
Beheer criteriumcontroles 3/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Haridas Kanani
Algemeen directeur
₹12.7m
Totale compensatie
| Percentage CEO-salaris | 99.6% |
| Dienstverband CEO | 35.7yrs |
| Eigendom CEO | 43.6% |
| Management gemiddelde ambtstermijn | 3yrs |
| Gemiddelde ambtstermijn bestuur | 8.4yrs |
Recente managementupdates
Recent updates
Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%
Sep 20
We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings
May 08Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts
May 05After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar
Apr 26Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?
Apr 12Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75
Aug 11Neogen Chemicals Limited (NSE:NEOGEN) Just Reported Earnings, And Analysts Cut Their Target Price
Aug 10Here's Why I Think Neogen Chemicals (NSE:NEOGEN) Is An Interesting Stock
Feb 09Neogen Chemicals' (NSE:NEOGEN) Returns On Capital Not Reflecting Well On The Business
Sep 21Neogen Chemicals' (NSE:NEOGEN) Dividend Will Be Increased To ₹2.25
Sep 05Neogen Chemicals (NSE:NEOGEN) Will Pay A Larger Dividend Than Last Year At ₹2.25
Aug 11Does Neogen Chemicals (NSE:NEOGEN) Deserve A Spot On Your Watchlist?
Jun 04Should You Think About Buying Neogen Chemicals Limited (NSE:NEOGEN) Now?
May 24Neogen Chemicals (NSE:NEOGEN) May Have Issues Allocating Its Capital
Apr 05Is Neogen Chemicals Limited's(NSE:NEOGEN) Recent Stock Performance Tethered To Its Strong Fundamentals?
Mar 07Should You Buy Neogen Chemicals Limited (NSE:NEOGEN) For Its Dividend?
Feb 21
Does Neogen Chemicals (NSE:NEOGEN) Have A Healthy Balance Sheet?
Jan 26Could The Neogen Chemicals Limited (NSE:NEOGEN) Ownership Structure Tell Us Something Useful?
Jan 13The Returns At Neogen Chemicals (NSE:NEOGEN) Provide Us With Signs Of What's To Come
Dec 31Don't Ignore The Fact That This Insider Just Sold Some Shares In Neogen Chemicals Limited (NSE:NEOGEN)
Dec 18Neogen Chemicals Limited (NSE:NEOGEN) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Dec 07If You Had Bought Neogen Chemicals (NSE:NEOGEN) Shares A Year Ago You'd Have Earned 70% Returns
Nov 23Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | ₹374m |
| Mar 31 2024 | ₹13m | ₹13m | ₹357m |
| Dec 31 2023 | n/a | n/a | ₹330m |
| Sep 30 2023 | n/a | n/a | ₹467m |
| Jun 30 2023 | n/a | n/a | ₹486m |
| Mar 31 2023 | ₹8m | ₹8m | ₹500m |
| Dec 31 2022 | n/a | n/a | ₹513m |
| Sep 30 2022 | n/a | n/a | ₹471m |
| Jun 30 2022 | n/a | n/a | ₹484m |
| Mar 31 2022 | ₹6m | ₹6m | ₹446m |
| Dec 31 2021 | n/a | n/a | ₹383m |
| Sep 30 2021 | n/a | n/a | ₹364m |
| Jun 30 2021 | n/a | n/a | ₹326m |
| Mar 31 2021 | ₹6m | ₹6m | ₹313m |
| Dec 31 2020 | n/a | n/a | ₹293m |
| Sep 30 2020 | n/a | n/a | ₹290m |
| Jun 30 2020 | n/a | n/a | ₹293m |
| Mar 31 2020 | ₹5m | ₹5m | ₹287m |
| Dec 31 2019 | n/a | n/a | ₹301m |
| Sep 30 2019 | n/a | n/a | ₹262m |
| Jun 30 2019 | n/a | n/a | ₹225m |
| Mar 31 2019 | ₹5m | ₹5m | ₹209m |
| Mar 31 2018 | ₹3m | ₹3m | ₹110m |
Compensatie versus markt: De totale vergoeding ($USD 150.42K ) Haridas } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 364.13K ).
Compensatie versus inkomsten: De beloning van Haridas is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.
CEO
Haridas Kanani (78 yo)
35.7yrs
Tenure
₹12,650,000
Compensatie
Mr. Haridas Thakarshi Kanani, B.Tech (Chem), M.I.I.Ch.E. serves as the Chairman and Managing Director of Neogen Chemicals Limited and serves as its Director since March 07, 1989. He oversees the manufactur...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & MD | no data | ₹12.65m | 43.63% ₹ 25.2b | |
| MD & Executive Director | 7.3yrs | ₹19.85m | 7.59% ₹ 4.4b | |
| Director of Operations & Whole Time Director | no data | ₹9.15m | 0.00030% ₹ 173.0k | |
| Chief Financial Officer | less than a year | geen gegevens | geen gegevens | |
| Company Secretary & Compliance Officer | 5yrs | ₹690.56k | geen gegevens | |
| Senior General Manager of Marketing | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Human Resource | no data | geen gegevens | geen gegevens | |
| Senior Vice President of Business Development | 1.1yrs | geen gegevens | geen gegevens |
3.0yrs
Gemiddelde duur
71yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van NEOGEN wordt beschouwd als ervaren (gemiddelde ambtstermijn 3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Chairman & MD | 35.7yrs | ₹12.65m | 43.63% ₹ 25.2b | |
| MD & Executive Director | 11.3yrs | ₹19.85m | 7.59% ₹ 4.4b | |
| Director of Operations & Whole Time Director | 9.3yrs | ₹9.15m | 0.00030% ₹ 173.0k | |
| Non Executive & Non-Independent Director | 7.5yrs | geen gegevens | 0.85% ₹ 491.7m | |
| Independent Non-Executive Director | 12.2yrs | ₹500.00k | 0.0098% ₹ 5.6m | |
| Independent Non-Executive Director | 10.2yrs | ₹400.00k | 0.00014% ₹ 80.7k | |
| Independent Non-Executive Director | 6.1yrs | ₹300.00k | geen gegevens | |
| Independent Non-Executive Woman Director | 6.1yrs | ₹500.00k | geen gegevens | |
| Additional Non-Executive Independent Director | less than a year | geen gegevens | geen gegevens | |
| Additional Independent Director | less than a year | geen gegevens | geen gegevens |
8.4yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van NEOGEN wordt beschouwd als ervaren (gemiddelde ambtstermijn 8.4 jaar).